Aankondiging • Jul 15
Emami Limited to Report Q1, 2027 Results on Aug 04, 2026 Emami Limited announced that they will report Q1, 2027 results on Aug 04, 2026 Price Target Changed • Jun 10
Price target decreased by 8.2% to ₹545 Down from ₹594, the current price target is an average from 22 analysts. New target price is 38% above last closing price of ₹395. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₹18.66 for next year compared to ₹17.76 last year. Reported Earnings • May 22
Full year 2026 earnings: EPS and revenues miss analyst expectations Full year 2026 results: EPS: ₹17.76 (down from ₹18.48 in FY 2025). Revenue: ₹38.6b (up 1.5% from FY 2025). Net income: ₹7.75b (down 3.9% from FY 2025). Profit margin: 20% (down from 21% in FY 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 6.3%. Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Aankondiging • May 21
Emami Limited, Annual General Meeting, Aug 25, 2026 Emami Limited, Annual General Meeting, Aug 25, 2026. Aankondiging • Apr 21
Emami Limited to Report Q4, 2026 Results on May 21, 2026 Emami Limited announced that they will report Q4, 2026 results on May 21, 2026 Declared Dividend • Feb 06
Dividend of ₹6.00 announced Shareholders will receive a dividend of ₹6.00. Ex-date: 10th February 2026 Payment date: 6th March 2026 Dividend yield will be 2.4%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is covered by both earnings (55% earnings payout ratio) and cash flows (76% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 27% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 05
Third quarter 2026 earnings: EPS exceeds analyst expectations Third quarter 2026 results: EPS: ₹7.32 (up from ₹6.39 in 3Q 2025). Revenue: ₹11.7b (up 12% from 3Q 2025). Net income: ₹3.19b (up 14% from 3Q 2025). Profit margin: 27% (in line with 3Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 34%. Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 7% per year. Aankondiging • Jan 07
Emami Limited to Report Q3, 2026 Results on Feb 04, 2026 Emami Limited announced that they will report Q3, 2026 results on Feb 04, 2026 Price Target Changed • Nov 24
Price target decreased by 7.0% to ₹653 Down from ₹703, the current price target is an average from 24 analysts. New target price is 29% above last closing price of ₹507. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹18.90 for next year compared to ₹18.48 last year. Declared Dividend • Nov 12
Dividend of ₹4.00 announced Shareholders will receive a dividend of ₹4.00. Ex-date: 14th November 2025 Payment date: 9th December 2025 Dividend yield will be 1.9%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is covered by both earnings (23% earnings payout ratio) and cash flows (51% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 36% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 11
Second quarter 2026 earnings: EPS and revenues miss analyst expectations Second quarter 2026 results: EPS: ₹3.40 (down from ₹4.87 in 2Q 2025). Revenue: ₹8.20b (down 7.9% from 2Q 2025). Net income: ₹1.48b (down 30% from 2Q 2025). Profit margin: 18% (down from 24% in 2Q 2025). Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) also missed analyst estimates by 14%. Revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 6% per year. Aankondiging • Oct 10
Emami Limited to Report Q2, 2026 Results on Nov 10, 2025 Emami Limited announced that they will report Q2, 2026 results on Nov 10, 2025 Reported Earnings • Aug 01
First quarter 2026 earnings: EPS and revenues exceed analyst expectations First quarter 2026 results: EPS: ₹3.76 (up from ₹3.50 in 1Q 2025). Revenue: ₹9.26b (up 2.2% from 1Q 2025). Net income: ₹1.64b (up 7.6% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) also surpassed analyst estimates by 21%. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 11% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jul 02
Emami Limited to Report Q1, 2026 Results on Jul 31, 2025 Emami Limited announced that they will report Q1, 2026 results on Jul 31, 2025 Aankondiging • Jun 19
Blackstone Inc. (NYSE:BX) acquired South City Projects (Kolkata) Limited from Merlin Group, Sureka Group, Emami Limited (BSE:531162), JB Group, Shrachi Group Limited and Rameswara Group for INR 32.5 billion. Blackstone Inc. (NYSE:BX) acquired South City Projects (Kolkata) Limited from Merlin Group, Sureka Group, Emami Limited (BSE:531162), JB Group, Shrachi Group Limited and Rameswara Group for INR 32.5 billion on June 17, 2025. A cash consideration of INR 32.5 billion will be paid by Blackstone Inc. As part of consideration, INR 32.5 billion is paid towards common equity of South City Projects (Kolkata) Limited.
Deepak Jodhani, Shourya Sengupta, Gaurav Dasgupta, Anisha Chand, Sanchit Agarwal, Deepak Kumar, Rajiv Bhatnagar and Ishaan Khanna of Khaitan & Co. acted as legal advisor for Blackstone Inc.
Blackstone Inc. (NYSE:BX) completed the acquisition of South City Projects (Kolkata) Limited from Merlin Group, Sureka Group, Emami Limited (BSE:531162), JB Group, Shrachi Group Limited and Rameswara Group for INR 32.5 billion on June 17, 2025. Reported Earnings • May 17
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: ₹18.48 (up from ₹16.55 in FY 2024). Revenue: ₹38.8b (up 8.4% from FY 2024). Net income: ₹8.06b (up 12% from FY 2024). Profit margin: 21% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.2%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. Aankondiging • Apr 09
Emami Limited to Report Q4, 2025 Results on May 16, 2025 Emami Limited announced that they will report Q4, 2025 results on May 16, 2025 Aankondiging • Feb 17
Emami Limited Announces Resignation of Sandeep Kr. Sultania, Company Secretary & Compliance Officer and VP Sales Commercial, Effective February 28, 2025 Emami Limited announced that Mr. Sandeep Kr. Sultania, Company Secretary & Compliance Officer and VP Sales Commercial, of the Company has tendered his resignation vide his letter dated February 1, 2025 which has been accepted February 17, 2025. He will be relieved from the services of the Company effective close of business hours on February 28, 2025. Price Target Changed • Jan 30
Price target decreased by 8.4% to ₹709 Down from ₹773, the current price target is an average from 27 analysts. New target price is 24% above last closing price of ₹571. Stock is up 15% over the past year. The company is forecast to post earnings per share of ₹19.35 for next year compared to ₹16.55 last year. Reported Earnings • Jan 28
Third quarter 2025 earnings: EPS exceeds analyst expectations Third quarter 2025 results: EPS: ₹6.39 (up from ₹5.92 in 3Q 2024). Revenue: ₹10.6b (up 6.8% from 3Q 2024). Net income: ₹2.79b (up 8.0% from 3Q 2024). Profit margin: 26% (in line with 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.6%. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year. Aankondiging • Dec 27
Emami Limited to Report Q3, 2025 Results on Jan 27, 2025 Emami Limited announced that they will report Q3, 2025 results on Jan 27, 2025 Price Target Changed • Nov 16
Price target decreased by 7.2% to ₹805 Down from ₹867, the current price target is an average from 26 analysts. New target price is 25% above last closing price of ₹643. Stock is up 31% over the past year. The company is forecast to post earnings per share of ₹19.26 for next year compared to ₹16.55 last year. Declared Dividend • Nov 09
First half dividend of ₹4.00 announced Dividend of ₹4.00 is the same as last year. Ex-date: 18th November 2024 Payment date: 7th December 2024 Dividend yield will be 1.2%, which is lower than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (23% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased by an average of 10% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 42% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 08
Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2025 results: EPS: ₹4.87 (up from ₹4.09 in 2Q 2024). Revenue: ₹9.12b (up 5.5% from 2Q 2024). Net income: ₹2.13b (up 19% from 2Q 2024). Profit margin: 23% (up from 21% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates by 17%. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 6% per year. Aankondiging • Oct 16
Emami Limited to Report Q2, 2025 Results on Nov 07, 2024 Emami Limited announced that they will report Q2, 2025 results on Nov 07, 2024 Price Target Changed • Aug 02
Price target increased by 8.4% to ₹778 Up from ₹718, the current price target is an average from 25 analysts. New target price is approximately in line with last closing price of ₹779. Stock is up 73% over the past year. The company is forecast to post earnings per share of ₹20.00 for next year compared to ₹16.55 last year. Reported Earnings • Aug 02
First quarter 2025 earnings: EPS misses analyst expectations First quarter 2025 results: EPS: ₹3.50 (up from ₹3.13 in 1Q 2024). Revenue: ₹9.17b (up 11% from 1Q 2024). Net income: ₹1.53b (up 11% from 1Q 2024). Profit margin: 17% (in line with 1Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 49%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 11% per year. Aankondiging • Jul 12
Emami Limited to Report Q1, 2025 Results on Aug 01, 2024 Emami Limited announced that they will report Q1, 2025 results on Aug 01, 2024 Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₹699, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 53x in the Personal Products industry in India. Total returns to shareholders of 36% over the past three years. Price Target Changed • Jun 01
Price target increased by 8.2% to ₹613 Up from ₹566, the current price target is an average from 27 analysts. New target price is approximately in line with last closing price of ₹626. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₹19.19 for next year compared to ₹16.55 last year. Reported Earnings • May 30
Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023) Full year 2024 results: EPS: ₹16.55 (up from ₹14.50 in FY 2023). Revenue: ₹36.2b (up 6.4% from FY 2023). Net income: ₹7.24b (up 13% from FY 2023). Profit margin: 20% (up from 19% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Aankondiging • Mar 28
Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd. Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd. on March 27, 2024. Prior to the transaction, Emami Limited (BSE:531162) held 95.36%. Brillare Science Pvt. Ltd. reported revenue of INR 197.1 million for FY 2022-23. The expected date of acquisition is on March 27, 2024. Declared Dividend • Feb 11
Dividend of ₹4.00 announced Dividend of ₹4.00 is the same as last year. Ex-date: 16th February 2024 Payment date: 10th March 2024 Dividend yield will be 1.7%, which is higher than the industry average of 1.4%. Sustainability & Growth The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. Reported Earnings • Feb 10
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: ₹5.92 (up from ₹5.37 in 3Q 2023). Revenue: ₹10.1b (up 3.1% from 3Q 2023). Net income: ₹2.58b (up 9.0% from 3Q 2023). Profit margin: 26% (up from 24% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 2.0%. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Aankondiging • Feb 09
Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24 Board of Directors of Emami Limited at its meeting held i.e. 9th February, 2024 has inter-alia, Considered and approved payment of Second Interim Dividend @400%, (i.e., INR 4/- per equity share on equity share of INR 1/- each) for the Financial Year 2023-24. The Record date for ascertaining the names of the members/Beneficial Owners who will be entitled to receive the Second Interim Dividend is 19th February, 2024 as intimated vide letter dated 11th January, 2024. Valuation Update With 7 Day Price Move • Jan 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹573, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 52x in the Personal Products industry in India. Total returns to shareholders of 42% over the past three years. Aankondiging • Nov 08
Emami Limited Declares Interim Dividend for the Financial Year 2023-24 The Board of Directors of Emami Limited in its meeting held on November 06, 2023, Considered and approved payment of First Interim Dividend @ 400%, (i.e., INR 4/- per equity share on equity share of INR 1/- each) for the Financial Year 2023-24. The Record date for ascertaining the names of the members who will be entitled to receive the Interim Dividend is 15 November, 2023. Reported Earnings • Nov 07
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Second quarter 2024 results: EPS: ₹4.09 (down from ₹4.17 in 2Q 2023). Revenue: ₹8.76b (up 7.6% from 2Q 2023). Net income: ₹1.79b (down 3.1% from 2Q 2023). Profit margin: 20% (down from 23% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 5.6%. Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 8.8% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Aankondiging • Oct 20
Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited on September 28, 2023. As of FY 2022-23, Axiom Ayurveda Private Limited reported turnover of INR 1.3 billion. The deal is expected to be completed within one month.Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited on October 18, 2023. Aankondiging • Sep 29
Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited. Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited on September 28, 2023. As of FY 2022-23, Axiom Ayurveda Private Limited reported turnover of INR 1.3 billion. The deal is expected to be completed within one month. Aankondiging • Sep 23
Emami Limited Announces Change in Management Emami Limited informed on the change in Senior Management Personnel (SMP). Appointment of Mr. Manish Gupta, President - Sales, Consumer Care Division. Brief Profile: Mr. Manish Gupta has a degree in Engineering from REC, Kurukshetra, a PGDMB degree from XLRI, Jamshedpur. He carries more than 25 years of professional experience in FMCG Sales &Distribution. He has gained first hand experience as a brand leader, retailer as well as a distributor. He has rich professional experience having worked with Reckitt, Walmart and GSK Consume. Prior to joining Emami Ltd, Mr. Manish Gupta was associated with Lynks Logistics (Swiggy group) as Chief Business Officer, helping them build an organized FMCG distribution set-up. Aankondiging • Sep 22
Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162). Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162) on September 20, 2023.Manipal Health Enterprises Pvt Ltd completed the acquisition of 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162) on September 20, 2023. Aankondiging • Sep 06
Emami Limited Announces Changes to the Senior Management Personnel Emami Limited announced changes to the Senior Management Personnel. The company announced appointment of Dr. Rajiva kumar Rai as the Head R&D Health Care Division with effect from September 1, 2023. Dr. Rai has completed B.Sc, B.A.M.S., M.D. (Ayurveda) & PhD from the Institute of Medical Sciences, BHU. He brings with him more than 27 years of diverse experience in product ideation and development for healthcare, clinical research and regulatory affairs in healthcare, foods and personal care products. He also holds several granted patents and has many published papers in peer-reviewed journals. Dr. Rai is associated with industry associations and is the General Secretary of AMAM and Chair of Ayush Committee at PHD CCI Delhi. The company announced shift of Dr. C. K. Katiyar Shift from employee role to advisory role (no more a SMP). Recent Insider Transactions • Aug 19
Insider recently bought ₹1.0m worth of stock On the 16th of August, Rajiv Khaitan bought around 2k shares on-market at roughly ₹520 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought ₹903k more in shares than they have sold in the last 12 months. Aankondiging • Aug 18
Emami May Seal AMRI Sale to Manipal Group This Month Emami Limited (BSE:531162) expects to conclude the sale of its hospital business, AMRI Hospitals Ltd., this month to The Manipal Group of Companies for about INR 24,000 million, after months of negotiations and legal battles, said industry executives. About INR 16,500 million of the proceeds of the deal will be utilised for servicing the existing debt of AMRI Hospitals which will make the business completely debt-free, the executives told. Price Target Changed • Aug 09
Price target increased by 7.6% to ₹517 Up from ₹481, the current price target is an average from 23 analysts. New target price is approximately in line with last closing price of ₹515. Stock is up 12% over the past year. The company is forecast to post earnings per share of ₹17.85 for next year compared to ₹14.50 last year. Aankondiging • Aug 09
Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023 Emami Limited announced cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management effective from the closing hours of July 31, 2023. Reported Earnings • Aug 03
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: ₹14.50 (down from ₹18.89 in FY 2022). Revenue: ₹34.1b (up 6.9% from FY 2022). Net income: ₹6.40b (down 24% from FY 2022). Profit margin: 19% (down from 26% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.1%. Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Aankondiging • Aug 02
Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23 Emami Limited announced that at the AGM to be held on August 23, 2023, the company proposed the payment of two Interim Dividends aggregating to INR 8/- per equity share declared for the financial year 2022-23. Aankondiging • Jul 29
Emami Limited, Annual General Meeting, Aug 23, 2023 Emami Limited, Annual General Meeting, Aug 23, 2023, at 11:30 Indian Standard Time. Aankondiging • Jul 13
Emami Limited to Report Q1, 2024 Results on Aug 07, 2023 Emami Limited announced that they will report Q1, 2024 results on Aug 07, 2023 Aankondiging • May 27
Emami Limited Approves Executive Changes Emami Limited at its board meeting held on May 25, 2023 approved the appointment of Shri Sandeep Kumar Sultania as the Company Secretary & Compliance Officer of the Company in place of the retiring Company Secretary & Compliance Officer of the company Shri A. K. Joshi with effect from June 01, 2023. Mr. Sandeep Kumar Sultania is a Chartered Accountant, Company Secretary, Cost & Management Accountant and Master in Business Finance (MBF) by qualification. Apart from holding a Master’s degree in Commerce, he also holds a Diploma in Information and System Audit (DISA). He is life member of Direct Taxes Professionals’ Association(DTPA) and VIP Road Chartered Accountant’s Association. He was selected as Invitee in the Members in Industry & Business Committee of EIRC of The Institute of Chartered Accountants of India for the year 2021-2022. Mr. Sultania started his career with Ideal Financing Corporation Ltd. He later joined Manaksia group where he was associated for 19 years and worked in various capacities including Company Secretary and Chief Financial Officer of Manaksia Industries Limited. Prior to joining Company, he was Chief Financial Officer of SREI Infrastructure Finance Limited. He joined Emami group with effect from 1 January 2022 as Head of Sales Commercial and is presently looking after depot management, coordination with CFAs, monitoring of various trade spends, GST and other statutory compliances related to depot operation. He has over 25 years of experience in the field of Financial Management, Auditing, Taxation, Budgeting and MIS, dealing with Banks & Financial Institutions, statutory and compliance function. Reported Earnings • May 26
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: ₹14.50 (down from ₹18.89 in FY 2022). Revenue: ₹34.7b (up 8.9% from FY 2022). Net income: ₹6.40b (down 24% from FY 2022). Profit margin: 18% (down from 26% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.1%. Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth. Price Target Changed • Feb 07
Price target decreased by 7.3% to ₹510 Down from ₹550, the current price target is an average from 23 analysts. New target price is 24% above last closing price of ₹412. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₹15.22 for next year compared to ₹18.89 last year. Reported Earnings • Feb 06
Third quarter 2023 earnings: EPS exceeds analyst expectations Third quarter 2023 results: EPS: ₹5.37 (up from ₹4.94 in 3Q 2022). Revenue: ₹9.83b (up 1.1% from 3Q 2022). Net income: ₹2.37b (up 7.8% from 3Q 2022). Profit margin: 24% (up from 23% in 3Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.9%. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Aankondiging • Jan 04
Emami Limited to Report Q3, 2023 Results on Feb 03, 2023 Emami Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 03, 2023 Reported Earnings • Nov 16
Second quarter 2023 earnings: EPS exceeds analyst expectations Second quarter 2023 results: EPS: ₹4.17 (in line with 2Q 2022). Revenue: ₹8.48b (up 7.4% from 2Q 2022). Net income: ₹1.84b (flat on 2Q 2022). Profit margin: 22% (down from 24% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.4%. Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 13
Second quarter 2023 earnings: EPS exceeds analyst expectations Second quarter 2023 results: EPS: ₹4.17 (in line with 2Q 2022). Revenue: ₹8.56b (up 8.5% from 2Q 2022). Net income: ₹1.84b (flat on 2Q 2022). Profit margin: 22% (down from 24% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.4%. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Personal Products industry in India. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jul 30
First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022) First quarter 2023 results: EPS: ₹1.67 (down from ₹1.75 in 1Q 2022). Revenue: ₹7.85b (up 19% from 1Q 2022). Net income: ₹738.3m (down 5.1% from 1Q 2022). Profit margin: 9.4% (down from 12% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 9.6%, compared to a 11% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 15
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₹18.88 (up from ₹10.23 in FY 2021). Revenue: ₹31.9b (up 11% from FY 2021). Net income: ₹8.39b (up 85% from FY 2021). Profit margin: 26% (up from 16% in FY 2021). The increase in margin was primarily driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 48%. Over the next year, revenue is forecast to grow 13%, compared to a 9.7% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. 
